Jersey City-based Character Biosciences, a company specializing in genetics-guided drug discovery and development, has announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative treatments for patients with age-related macular degeneration (AMD). This relationship, initiated in 2024, brings together Bausch + Lomb's experience in ophthalmology with Character Bio's integrated [...] The post Character Biosciences Collaborating with Bausch + Lomb appeared first on New Jersey Business Magazine.
Character is a California-based precision medicine platform that offers solutions such as drug development and genomic research for the treatment of age-related diseases.